tixagevimab and cilgavimab is Evusheld. Not sure I agree with the wording in the conclusion about Evusheld. Note the word "may" and "blocking" is totally different from preventing severe disease or hospitalization. Also very small sample size.
Nguyen
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer
https://jamanetwork.com/journals/jam...6-00ed1fe3d741
Hybrid Mode
